PDCD1 and rheumatoid arthritis: These findings led to the study of the PD-1 pathway contribution in malignancies and several autoimmune diseases, as type 1 diabetes mellitus, multiple sclerosis, idiopathic inflammatory bowel disease and Rheumatoid Arthritis (RA).